CHEBI:87715 - prasugrel

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name prasugrel
ChEBI ID CHEBI:87715
Definition A racemate comprising equal amounts of (R)- and (S)-prasugrel. Used (as its hydrochloride salt) to prevent blood clots in people with acute coronary syndrome who are undergoing a procedure after a recent heart attack or stroke, and in people with certain disorders of the heart or blood vessels.
Stars This entity has been manually annotated by the ChEBI Team.
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C20H20FNO3S
Net Charge 0
Average Mass 373.443
Monoisotopic Mass 373.11479
Roles Classification
Biological Role(s): platelet glycoprotein-IIb/IIIa receptor antagonist
Antagonist of platelet surface glycoprotein-IIb/IIIa which has a key role in hemostasis and thrombosis such as platelet adhesion and aggregation.
P2Y12 receptor antagonist
An antagonist at the P2Y12 receptor
Application(s): platelet glycoprotein-IIb/IIIa receptor antagonist
Antagonist of platelet surface glycoprotein-IIb/IIIa which has a key role in hemostasis and thrombosis such as platelet adhesion and aggregation.
cardiovascular drug
A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing prasugrel (CHEBI:87715) has part (R)-prasugrel (CHEBI:87725)
prasugrel (CHEBI:87715) has part (S)-prasugrel (CHEBI:87724)
prasugrel (CHEBI:87715) has role cardiovascular drug (CHEBI:35554)
prasugrel (CHEBI:87715) has role P2Y12 receptor antagonist (CHEBI:68563)
prasugrel (CHEBI:87715) has role platelet glycoprotein-IIb/IIIa receptor antagonist (CHEBI:50433)
prasugrel (CHEBI:87715) has role prodrug (CHEBI:50266)
prasugrel (CHEBI:87715) is a racemate (CHEBI:60911)
IUPAC Name
rac-5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
INN Source
prasugrel ChemIDplus
Synonyms Sources
(±)-prasugrel ChEBI
(RS)-prasugrel ChEBI
CS 747 ChemIDplus
CS-747 ChemIDplus
HSDB 7995 ChemIDplus
LY 640315 ChemIDplus
LY-640315 ChemIDplus
LY640315 ChemIDplus
rac-prasugrel ChEBI
racemic prasugrel ChEBI
Manual Xrefs Databases
DB06209 DrugBank
HMDB0015625 HMDB
Prasugrel Wikipedia
View more database links
Registry Numbers Types Sources
150322-43-3 CAS Registry Number ChemIDplus
9008623 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
17353347 PubMed citation Europe PMC
24433187 PubMed citation Europe PMC
24838516 PubMed citation Europe PMC
25085573 PubMed citation Europe PMC
25089928 PubMed citation Europe PMC
25275609 PubMed citation Europe PMC
25400062 PubMed citation Europe PMC
25557052 PubMed citation Europe PMC
25614494 PubMed citation Europe PMC
25616919 PubMed citation Europe PMC
25633751 PubMed citation Europe PMC
25660584 PubMed citation Europe PMC
25697420 PubMed citation Europe PMC
25703419 PubMed citation Europe PMC
25728845 PubMed citation Europe PMC
25737192 PubMed citation Europe PMC
25809392 PubMed citation Europe PMC
25893318 PubMed citation Europe PMC
25959558 PubMed citation Europe PMC
25970631 PubMed citation Europe PMC
26051687 PubMed citation Europe PMC
26113418 PubMed citation Europe PMC
26113480 PubMed citation Europe PMC
26205445 PubMed citation Europe PMC
26216931 PubMed citation Europe PMC
26270719 PubMed citation Europe PMC
Last Modified
22 February 2017